Connect with us
Bioceres shares fell 36% to US$0.84, entering penny-stock territory and nearing delisting risk. Once valued near US$900 million, the company now sits around US$53 million. Financial...
ByBug, a Chilean biotech startup, uses genetically edited black soldier fly larvae as biofactories to produce oral therapeutic proteins for animal health. The approach cuts costs...
Founded in 2024, Twogee Biotech develops customer-specific enzyme solutions that convert low-value biomass residues into sustainable second-generation raw materials. Using a predictive, industry-oriented platform, the company...
CIPM’s January 28, 2026 meeting proposed full or partial funding for three new drugs, including an orphan drug, plus multiple indication expansions. Decisions covered rare diseases,...
Eli Lilly has partnered with Dresden-based Seamless Therapeutics to develop a recombinase-based gene therapy for genetically caused hearing loss. Seamless will engineer precise recombinases, while Lilly...
BioNTech shares are off to a strong start in 2026, gaining over 21 percent in both European and U.S. markets. Analysts remain optimistic, with most recommending...
Spain’s Innovative Medicines Platform outlined its 2026 strategy, centered on leadership in clinical trials, biomedical data use, and the future Biotechnology Law. Announced by its coordinating...
The European Commission’s Safe Hearts Plan promotes proactive, precision cardiovascular care using innovation, digitalization, and responsible AI. Spanish radiology and cardiac imaging societies strongly support it,...
CRISPR/Cas systems are vital bioeconomy tools. Researchers discovered a new CRISPR defense using Cas12a3, which uniquely cuts tRNA tails, halting protein synthesis and pushing cells into...
Nvidia and Eli Lilly are launching a joint AI innovation lab in the San Francisco Bay Area to accelerate drug discovery and manufacturing. Backed by up...